Добірка наукової літератури з теми "Cardiac metabolic syndrome"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cardiac metabolic syndrome".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cardiac metabolic syndrome"
Cheng, Tsung O. "Cardiac syndrome X versus metabolic syndrome X." International Journal of Cardiology 119, no. 2 (July 2007): 137–38. http://dx.doi.org/10.1016/j.ijcard.2006.06.062.
Повний текст джерелаChiavelli, H., M. Lachaux, V. Tardif, A. Dumesnil, L. Nicol, G. Riou, D. Godefroy, et al. "Cardiac lymphatics in metabolic-syndrome related cardiac dysfunstion." Archives of Cardiovascular Diseases Supplements 12, no. 2-4 (October 2020): 239. http://dx.doi.org/10.1016/j.acvdsp.2020.03.095.
Повний текст джерелаBugger, Heiko, and E. Dale Abel. "The Metabolic Syndrome and Cardiac Function." Advances in Pulmonary Hypertension 7, no. 3 (August 1, 2008): 332–36. http://dx.doi.org/10.21693/1933-088x-7.3.332.
Повний текст джерелаYavelov, I. S. "SUDDEN CARDIAC DEATH AND METABOLIC SYNDROME." Journal of Clinical Practice 5, no. 4 (December 15, 2014): 53–59. http://dx.doi.org/10.17816/clinpract5453-59.
Повний текст джерелаChahine, Mohamed. "Cardiac Metabolic State and Brugada Syndrome." Circulation Research 105, no. 8 (October 9, 2009): 721–23. http://dx.doi.org/10.1161/circresaha.109.208405.
Повний текст джерелаFitchett, David, and Kim A. Connelly. "Impaired Cardiac Function in Metabolic Syndrome." Canadian Journal of Cardiology 30, no. 3 (March 2014): 270–71. http://dx.doi.org/10.1016/j.cjca.2014.01.012.
Повний текст джерелаLavie, Carl J., and Richard V. Milani. "Metabolic Syndrome, Hostility, and Cardiac Rehabilitation." American Journal of Cardiology 96, no. 11 (December 2005): 1615. http://dx.doi.org/10.1016/j.amjcard.2005.08.001.
Повний текст джерелаHaq, M. Maksumul, and ZA Latif. "'Angry Fat' and Metabolic Syndrome." Ibrahim Cardiac Medical Journal 1, no. 2 (January 30, 2013): 5–6. http://dx.doi.org/10.3329/icmj.v1i2.13543.
Повний текст джерелаYang, Yijun, Justin Kurian, Giana Schena, Jaslyn Johnson, Hajime Kubo, Joshua G. Travers, Chunya Kang, et al. "Cardiac Remodeling During Pregnancy With Metabolic Syndrome." Circulation 143, no. 7 (February 16, 2021): 699–712. http://dx.doi.org/10.1161/circulationaha.120.051264.
Повний текст джерелаAsrih, Mohamed, François Mach, Alessio Nencioni, Franco Dallegri, Alessandra Quercioli, and Fabrizio Montecucco. "Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome." Mediators of Inflammation 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/367245.
Повний текст джерелаДисертації з теми "Cardiac metabolic syndrome"
Zibadi, Sherma. "Metabolic Syndrome-Induced Cardiac Fibrosis." Diss., The University of Arizona, 2009. http://hdl.handle.net/10150/195321.
Повний текст джерелаZullo, Melissa D. "Cardiovascular Disease Management and Functional Capacity in Patients With Metabolic Syndrome." Case Western Reserve University School of Graduate Studies / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1232721609.
Повний текст джерелаNAGATA, KOHZO, TOYOAKI MUROHARA, SHOGO WATANABE, YUURI TAKESHITA, SAE OHURA, TAMAYO MURASE, TAKUYA HATTORI, MIWA TAKATSU, and KEIJI TAKAHASHI. "Premature Cardiac Senescence in DahlS.Z-Lepr fa/Lepr fa Rats as a New Animal Model of Metabolic Syndrome." Nagoya University School of Medicine, 2014. http://hdl.handle.net/2237/19482.
Повний текст джерелаDonner, Daniel Giordano. "Therapeutic Effects of Selective Androgen Receptor Modulation in the Treatment of Cardiac, Metabolic and Bone Pathologies Associated with Androgen Decline and Obesity." Thesis, Griffith University, 2015. http://hdl.handle.net/10072/367789.
Повний текст джерелаThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Wachowiak, Paul Stephen. "Relationships among Cynical Hostility, Metabolic Syndrome, and Cardiac Structure and Function in Multi-Ethnic Post-Myocardial Infarction Patients: A Structural Modeling Approach." Scholarly Repository, 2009. http://scholarlyrepository.miami.edu/oa_dissertations/291.
Повний текст джерелаVidlund, Mårten. "Glutamate for metabolic intervention in coronary surgery : with special reference to the GLUTAMICS-trial." Doctoral thesis, Örebro universitet, Hälsoakademin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-19757.
Повний текст джерелаMaarman, Gerald Jerome. "The effect of CPT-1 inhibition on myocardial function and resistance to ischemia/reperfusion injury in a rodent model of the metabolic syndrome." Thesis, Stellenbosch : University of Stellenbosch, 2010. http://hdl.handle.net/10019.1/5354.
Повний текст джерелаENGLISH ABSTRACT: Background: Obesity is associated with dyslipidemia, insulin resistance and glucose intolerance and together these components characterise the metabolic syndrome (Dandona et al. 2005). In the state of obesity, there are high levels of circulating free fatty acids and increased rates of fatty oxidation which inhibit glucose oxidation. This: (i) reduce the heart‘s contractile ability, (ii) exacerbates ischemic/reperfusion injury and (iii) decreases cardiac mechanical function during reperfusion (Kantor et al. 2000; Liu et al. 2002; Taegtmeyer, 2000). Aim: The aim of our study was to investigate the effect of inhibiting fatty acid oxidation, with oxfenicine (4-Hydroxy-L-phenylglycine), on (i) cardiac mechanical function, (ii) mitochondrial respiration, (iii) myocardial tolerance to ischemia/reperfusion injury, (iv) CPT-I expression, MCAD expression, IRS-1 activation, total GLUT- 4 expression and (v) the RISK pathway (ERK42/44 and PKB/Akt). Methods: Male Wistar rats were fed a control rat chow diet or a high calorie diet (HCD) for 16 weeks. The HCD caused diet induced obesity (DIO). The animals were randomly divided into 4 groups [Control, DIO, Control + oxfen and DIO + oxfen]. The drug was administered for the last 8 weeks of feeding (200mg/kg/day). Animals were sacrificed and the hearts were perfused on the Langendorff perfusion system. After being subjected to regional ischemia and two hours of reperfusion, infarct size was determined. A separate series of animals were fed and/or treated and hearts were collected after 25 minutes global ischemia followed by 30 min reperfusion for determination of GLUT- 4, CPT-1, IRS -1, MCAD, ERK (42/44) and PKB/Akt expression/phosphorylation using Western blot analysis. A third series of hearts were excised and used for the isolation of mitochondria. Results: In the DIO rats, chronic oxfenicine treatment improved cardiac mechanical function by improving mitochondrial respiration. Oxfenicine inhibited CPT-1 expression but had no effect on MCAD or GLUT- 4 expression. Oxfenicine decreased IRS-1 iv expression, but not IRS-1 activation. Oxfenicine also improved myocardial tolerance to ischemia/reperfusion without activation of the RISK pathway (ERK & PKB). In the control rats, chronic oxfenicine treatment worsened cardiac mechanical function by adversely affecting mitochondrial respiration. Oxfenicine also worsened myocardial tolerance to ischemia/reperfusion in the control rats without changes in the RISK pathway (ERK & PKB). Oxfenicine had no effect on CPT-1, MCAD or GLUT- 4 expression. Oxfenicine increased IRS-1 expression, but not IRS-1 activity. Conclusion: Chronic oxfenicine treatment improved cardiac mechanical function and myocardial resistance to ischemia/reperfusion injury in obese animals, but worsened it in control animals. The improved cardiac mechanical function and tolerance to ischemia/reperfusion injury may be due to improvement in mitochondrial respiration.
AFRIKAANSE OPSOMMING: Agtergrond: Vetsug word geassosieer met dislipidemie, insulien weerstandigheid en glukose intoleransie, wat saam die metaboliese sindroom karakteriseer (Dandona et al. 2005). Met vetsug is daar ‗n hoë sirkulasie van vetsure, sowel as verhoogde vertsuur oksidasie wat gevolglik glukose oksidasie onderdruk. Dit: (i) verlaag die hart se vermoë om saam te trek, (ii) vererger isgemiese/herperfusie skade en (iv) verlaag kardiale effektiwiteit gedurende herperfusie (Kantor et al. 2000; Liu et al. 2002; Taegtmeyer, 2000). Doel: Die doel van die studie was om die effekte van vetsuur onderdrukking m.b.v. oksfenisien (4-Hidroksie-L-fenielglisien) op (i) meganiese hart funksie, (ii) mitokondriale respirasie, (iii) miokardiale toleransie teen isgemiese/herperfusie skade, (iv) CPT-I uitdrukking, MCAD uitdrukking, IRS-1 aktiwiteit, totale GLUT-4 uitdrukking en (v) die RISK pad (ERK42/44 en PKB/Akt) te ondersoek. Metodes: Manlike Wistar rotte was gevoer met ‗n kontrole rot dieet of ‗n hoë kalorie dieet (HKD) vir 16 weke. Die HKD lei tot dieet-geïnduseerde vetsug (DGV). Die diere was lukraak verdeel in 4 groepe [kontrole, DGV, kontrole + oksfen en DGV + oksfen]. Die behandeling met die middel was toegedien vir die laaste 8 weke van die voeding protokol (200mg/kg/dag). Die diere was geslag en die harte was geperfuseer op die Langendorff perfusie sisteem. Na blootstelling aan streeks- of globale isgemie en 2 ure herperfusie was infark groottes bepaal. ‗n Aparte reeks diere was gevoer en/of behandel en die harte was versamel na 25 minute globale isgemie gevolg deur 30 minute herperfusie vir die bepaling van GLUT-4, CPT 1, IRS -1, MCAD, ERK (42/44) en PKB/Akt uitdrukking/aktivering d.m.v. Western blot analise. ‗n Derde reeks diere was gebruik vir die isolasie van mitokondria. Resultate: In die DGV diere, het kroniese oksfenisien behandeling meganiese hart funksie verbeter d.m.v. die verbetering van mitokondriale respirasie. Oksfenisien het CPT-1 uitdrukking verlaag terwyl GLUT- 4 en MCAD uitdrukking nie geaffekteer was vi nie. Oksfenisien het IRS-1 uitdrukking verlaag, maar nie IRS-1 aktiwiteit nie. Oksfenisien het ook miokardiale weerstand teen isgemiese/herperfusie verbeter met sonder aktivering van die RISK pad (ERK & PKB). In die kontrole diere, het kroniese oksfenisien behandeling die meganiese hart funksie versleg d.m.v. negatiewe effekte op mitokondriale respirasie. Oksfenisien het die miokardiale weerstand teen isgemiese/herperfusie van die kontrole rotte versleg sonder veranderinge in die RISK pad (ERK & PKB). Oksfenisien het geen effek gehad op CPT-1, MCAD en GLUT-4 uitdrukking nie. Oksfenisien het IRS-1 uitdrukking verhoog, maar nie IRS-1 aktiwiteit nie. Samevatting: Kroniese oksfenisien behandeling het die meganiese hart funksie en miokardiale weerstand teen isgemiese/herperfusie skade in die vet diere verbeter, maar versleg in die kontrole diere. Hierdie verbetering van meganiese hart funksie en weerstand teen isgemiese/herperfusie skade kon dalk wees a.g.v. ‗n verbetering in mitokondriale respirasie.
Smith, Wayne. "A pathologic role for angiotensin II and endothelin-1 in cardiac remodelling and ischaemia and reperfusion injury in a rat model of the metabolic syndrome." Thesis, Link to the online version, 2006. http://hdl.handle.net/10019/1217.
Повний текст джерелаMittoux, Aurélia. "Évaluation de la mortalité chez les patients schizophrènes traités par des antipsychotiques dans des conditions normales de prescription en Europe et en Asie." Thesis, Lyon 1, 2011. http://www.theses.fr/2011LYO10268.
Повний текст джерелаFatica, Erica Marie. "Investigating Cardiac Metabolism in Barth Syndrome Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes." Cleveland State University / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=csu1556630870935279.
Повний текст джерелаКниги з теми "Cardiac metabolic syndrome"
Casaer, Michael P., and Greet Van den Berghe. Nutrition support in acute cardiac care. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0032.
Повний текст джерелаCasaer, Michael P., and Greet Van den Berghe. Nutrition support in acute cardiac care. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0032_update_001.
Повний текст джерелаCasaer, Michael P., and Greet Van den Berghe. Nutrition support in acute cardiac care. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199687039.003.0032_update_002.
Повний текст джерелаSchmid, Jean-Paul, and Hugo Saner. Ambulatory preventive care: outpatient clinics and primary care. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0023.
Повний текст джерелаSchmid, Jean-Paul, Hugo Saner, Paul Dendale, and Ines Frederix. Ambulatory preventive care: outpatient clinics and primary care. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199656653.003.0023_update_001.
Повний текст джерелаKaron, Barry L., and Naveen L. Pereira. Heart Failure and Cardiomyopathies. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0046.
Повний текст джерелаGluckman, Sir Peter, Mark Hanson, Chong Yap Seng, and Anne Bardsley. Magnesium in pregnancy and breastfeeding. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198722700.003.0021.
Повний текст джерелаSever, Mehmet Şükrü, and Raymond Vanholder. Acute kidney injury in polytrauma and rhabdomyolysis. Edited by Norbert Lameire. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0252_update_001.
Повний текст джерелаSchwitter, Juerg, and Jens Bremerich. Cardiac magnetic resonance in the intensive and cardiac care unit. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0023.
Повний текст джерелаSchwitter, Juerg, and Jens Bremerich. Cardiac magnetic resonance in the intensive and cardiac care unit. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0023_update_001.
Повний текст джерелаЧастини книг з теми "Cardiac metabolic syndrome"
Alpert, Martin A. "Obesity and Cardiac Disease." In Metabolic Syndrome, 619–39. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-11251-0_35.
Повний текст джерелаAlpert, Martin A., and Brent M. Parker. "Obesity and Cardiac Disease." In Metabolic Syndrome, 1–24. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-12125-3_35-1.
Повний текст джерелаSteinberger, Julia, and Aaron S. Kelly. "Obesity, Metabolic Syndrome and Type 2 Diabetes." In Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care, 499–507. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4619-3_53.
Повний текст джерелаTuran, Belma. "Role of Sodium-Glucose Co-transporters on Cardiac Function in Metabolic Syndrome Mammalians." In Biochemistry of Cardiovascular Dysfunction in Obesity, 125–44. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47336-5_7.
Повний текст джерелаHeidari-Foroozan, Mahsa, and Nima Rezaei. "Metabolic Encephalomyopathic Crises, Recurrent with Rhabdomyolysis, Cardiac Arrhythmias, and Neurodegeneration (MECRCN)." In Genetic Syndromes, 1–4. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-319-66816-1_1765-1.
Повний текст джерелаBagger, Jens Peder. "Myocardial Metabolism in Cardiac Syndrome X." In Developments in Cardiovascular Medicine, 81–89. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-5181-2_7.
Повний текст джерелаSternick, Eduardo Back. "Inherited Metabolic Diseases: Emphasis on Myocardial Disease and Arrhythmogenesis." In Clinical Approach to Sudden Cardiac Death Syndromes, 233–58. London: Springer London, 2009. http://dx.doi.org/10.1007/978-1-84882-927-5_19.
Повний текст джерелаChen, Wei. "Evolution of Metabolic Syndrome from Childhood." In Evolution of Cardio-Metabolic Risk from Birth to Middle Age:, 35–52. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-1451-9_4.
Повний текст джерелаJaquet, Kornelia, Andreas Mügge, and Nazha Hamdani. "Cardiac transcriptomic remodeling in metabolic syndrome." In Epigenetics in Cardiovascular Disease, 187–211. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-822258-4.00011-0.
Повний текст джерелаYanger, Sheryl. "Sudden Infant Death Syndrome." In Pediatric Emergencies, 35–36. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190073879.003.0004.
Повний текст джерелаТези доповідей конференцій з теми "Cardiac metabolic syndrome"
Stojanovska, Jadranka, El-Sayed Ibrahim, Slavica Nikolovska, and Thomas Chenevert. "Identifying cardiac magnetic resonance signatures of obesity phenotypes in metabolic syndrome using multi-echo DIXON imaging." In 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI 2016). IEEE, 2016. http://dx.doi.org/10.1109/isbi.2016.7493304.
Повний текст джерелаAlbarado-Ibañez, Alondra, Marcia Hiriart, Alejandro Frank Hoeflich, and Julian Torres-Jacome. "Assessment the change on rhythm cardiac produces by the metabolic syndrome in rats: using nonlinear methods." In 6th International Conference on Nonlinear Science and Complexity. São José dos Campos, Brazil: INPE Instituto Nacional de Pesquisas Espaciais, 2016. http://dx.doi.org/10.20906/cps/nsc2016-0019.
Повний текст джерелаGalerneau, Louis-Marie, Jean-Louis Pépin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Renaud Tamisier, and Philippe Caron. "Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?" In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.oa1802.
Повний текст джерелаAssad, Nour, Clifford Qualls, Lewis J. Smith, Alexander Arynchyn, Bharat Thyagarajan, David Jacobs, and Akshay Sood. "BMI-Defined Obesity Is A Stronger Predictor Than Metabolic Syndrome For Future Asthma Risk In Women- The Longitudinal Cardia Study." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6499.
Повний текст джерелаvan Zeller, M., O. K. Basoglu, J. Verbraecken, C. Lombardi, W. T. Mcnicholas, J. L. Pepin, P. Steiropoulos, et al. "Sleep characteristics and cardio-metabolic comorbidities in the OSA-COPD overlap syndrome: Data from the European Sleep Apnea Database (ESADA)." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.1459.
Повний текст джерелаFolts, J. D. "A MODEL OF ACUTE PLATELET THROMBUS FORMATION IN STENOSED CORONARY AND CAROTID ARTERIES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643712.
Повний текст джерелаЗвіти організацій з теми "Cardiac metabolic syndrome"
Czerwaty, Katarzyna, Karolina Dżaman, Krystyna Maria Sobczyk, and Katarzyna Irmina Sikrorska. The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0077.
Повний текст джерела